Out-of-Pocket Costs for Colonoscopy after Noninvasive Colorectal Cancer Screening among US Adults with Commercial and Medicare Insurance

TY - JOUR

T1 - Out-of-Pocket Costs for Colonoscopy after Noninvasive Colorectal Cancer Screening among US Adults with Commercial and Medicare Insurance

AU - Fendrick, A. Mark

AU - Princic, Nicole

AU - Miller-Wilson, Lesley Ann

AU - Wilson, Kathleen

AU - Limburg, Paul

N1 - Funding Information: Author Contributions: Ms Princic had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Fendrick, Miller-Wilson, Wilson, Limburg. Acquisition, analysis, or interpretation of data: Fendrick, Princic, Limburg. Drafting of the manuscript: Fendrick. Critical revision of the manuscript for important intellectual content: Princic, Miller-Wilson, Wilson, Limburg. Obtained funding: Miller-Wilson. Administrative, technical, or material support: Princic, Miller-Wilson, Wilson. Supervision: Fendrick, Miller-Wilson, Wilson, Limburg. Conflict of Interest Disclosures: Dr Fendrick reported serving as a consultant for AbbVie, Amgen, Bayer, Centivo, Community Oncology Association, Covered California, Eli Lilly and Company, EmblemHealth, Exact Sciences Corporation, Freedman HealthCare, GRAIL, Harvard University, Health & Wellness Innovations, Health at Scale Technologies, HealthCorum, Hygieia, Mallinckrodt Pharmaceuticals, MedZed, Merck & Co, Mercer, Montana Health CO-OP, Pair Team, Penguin Pay, Phathom Pharmaceuticals, Risalto Health, Risk International, Sempre Health, state of Minnesota, US Department of Defense, Virginia Center for Health Innovation, Wellth, Wildflower Health, Yale New Haven Health System, and Zansors; reported receiving research support from the Agency for Healthcare Research and Quality, Boehringer Ingelheim, Gary and Mary West Health Policy Center, Arnold Ventures, the Laura and John Arnold Foundation, National Pharmaceutical Council, Patient-Centered Outcomes Research Institute, Pharmaceutical Research and Manufacturers of America, the Robert Wood Johnson Foundation, Michigan Department of Health and Human Services, and Centers for Medicare & Medicaid Services; and reported serving as coeditor of the American Journal of Managed Care, a member of the Medicare Evidence Development & Coverage Advisory Committee, and a partner in V-BID Health. Mss Princic and Wilson reported being employed by IBM Watson Health, which received funding from Exact Sciences Corporation to conduct this study. Dr Miller-Wilson reported being employed by Exact Sciences Corporation. Dr Limburg reported serving as chief medical officer for screening at Exact Sciences Corporation through a contracted services agreement with Mayo Clinic; Dr Limburg and Mayo Clinic have contractual rights to receive royalties through this agreement.

PY - 2021/12/2

Y1 - 2021/12/2

UR - http://www.scopus.com/inward/record.url?scp=85120933138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120933138&partnerID=8YFLogxK

U2 - 10.1001/jamanetworkopen.2021.36798

DO - 10.1001/jamanetworkopen.2021.36798

M3 - Letter

C2 - 34854909

AN - SCOPUS:85120933138

SN - 2574-3805

VL - 4

JO - JAMA Network Open

JF - JAMA Network Open

IS - 12

M1 - e2136798

ER -